Bayesian Statistical Methods Guidance Drafted For Device Trial Sponsors
This article was originally published in The Gray Sheet
Executive Summary
FDA is vetting a draft guidance document on applying Bayesian statistics to device clinical trial design
You may also be interested in...
Comparative Effectiveness Researchers Look Beyond Randomized Trials
Researchers awaiting guidance from the Administration on how it will allocate $1.1 billion in stimulus funds for comparative effectiveness research are exploring ways to include alternatives to randomized clinical trials in gathering evidence to inform health care decisions
Comparative Effectiveness Researchers Look Beyond Randomized Trials
Researchers awaiting guidance from the Administration on how it will allocate $1.1 billion in stimulus funds for comparative effectiveness research are exploring ways to include alternatives to randomized clinical trials in gathering evidence to inform health care decisions
CDRH Promotes Bayesian Tool To Speed Approvals; Statistical Rigor Required
FDA is encouraging medical device firms to consider using Bayesian estimation in clinical trials to streamline regulatory timeframes